PAX Financial Group’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $499K | Sell |
7,228
-2,891
| -29% | -$200K | 0.1% | 144 |
|
|
2025
Q1 | $703K | Buy |
10,119
+4,719
| +87% | +$328K | 0.12% | 133 |
|
|
2024
Q4 | $465K | Buy |
5,400
+194
| +4% | +$16.7K | 0.08% | 174 |
|
|
2024
Q3 | $620K | Sell |
5,206
-1,195
| -19% | -$142K | 0.11% | 154 |
|
|
2024
Q2 | $914K | Sell |
6,401
-241
| -4% | -$34.4K | 0.18% | 102 |
|
|
2024
Q1 | $853K | Sell |
6,642
-566
| -8% | -$72.7K | 0.17% | 107 |
|
|
2023
Q4 | $853K | Sell |
7,208
-232
| -3% | -$27.5K | 0.18% | 105 |
|
|
2023
Q3 | $677K | Sell |
7,440
-388
| -5% | -$35.3K | 0.15% | 119 |
|
|
2023
Q2 | $633K | Sell |
7,828
-164
| -2% | -$13.3K | 0.14% | 129 |
|
|
2023
Q1 | $636K | Sell |
7,992
-1,486
| -16% | -$118K | 0.15% | 110 |
|
|
2022
Q4 | $641K | Sell |
9,478
-3,184
| -25% | -$215K | 0.16% | 103 |
|
|
2022
Q3 | $631K | Sell |
12,662
-234
| -2% | -$11.7K | 0.16% | 110 |
|
|
2022
Q2 | $719K | Sell |
12,896
-5,854
| -31% | -$326K | 0.18% | 90 |
|
|
2022
Q1 | $1.04M | Sell |
18,750
-1,054
| -5% | -$58.5K | 0.24% | 60 |
|
|
2021
Q4 | $1.11M | Sell |
19,804
-1,176
| -6% | -$65.9K | 0.25% | 59 |
|
|
2021
Q3 | $1.01M | Sell |
20,980
-856
| -4% | -$41.1K | 0.25% | 59 |
|
|
2021
Q2 | $915K | Buy |
21,836
+1,294
| +6% | +$54.2K | 0.23% | 57 |
|
|
2021
Q1 | $692K | Buy |
20,542
+3,640
| +22% | +$123K | 0.19% | 81 |
|
|
2020
Q4 | $590K | Buy |
16,902
+722
| +4% | +$25.2K | 0.18% | 72 |
|
|
2020
Q3 | $562K | Buy |
16,180
+1,946
| +14% | +$67.6K | 0.2% | 58 |
|
|
2020
Q2 | $466K | Buy |
14,234
+1,570
| +12% | +$51.4K | 0.18% | 66 |
|
|
2020
Q1 | $411K | Buy |
12,664
+2,912
| +30% | +$94.5K | 0.18% | 66 |
|
|
2019
Q4 | $313K | Buy |
+9,752
| New | +$313K | 0.13% | 86 |
|